Indeed, our present study show, for the first time, that the beneficial effects of PYR on cardiac contractile performance and rhythmicity in HF are associated with normalization of RyR2 Ser‐2814 phosphorylation and myocyte Ca cycling. The gene discussed is RYR2; the disease is hydrops fetalis.